The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases

Acta Physiologica Hungarica

Volumn 92, Issue 2, 2005, Pages 97-107

  Lelbach, A ^a   Muzes, Gy ^a   Feher, J ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

IGF binding proteins; IGF receptors; IGFBP proteases; Insulin like growth factors

Indexed keywords

CELL SURFACE RECEPTOR; GROWTH HORMONE; POLYPEPTIDE; PROTEINASE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; CELL TYPE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ENDOPEPTIDASES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; METALLOENDOPEPTIDASES; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECEPTOR, INSULIN; SOMATOMEDINS;

EID: 27144471355     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/APhysiol.92.2005.2.1     Document Type: Article

References (51)

1. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J et al.: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N. Engl. J. Med. 349, 2211-2222 (2003)
2. Bach LA, Rechler MM: Insulin-like growth factor binding proteins. Diabetes Reviews 3, 38-61 (1995)
3. Braulke T (1996): Origin of lysosomal proteins. In: Subcellular Biochemistry: Biology of the Lysosome, eds V. Lloyd JB, Mason RW, Plenum Press, New York, pp. 15-49
4. Butt AJ, Firth SM, Baxter RC: The IGF axis and programmed cell death. Immunol. Cell. Biol. 77, 256-262 (1999)
5. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR: Proteolytic cleavage of insulin-like growth factor binding protein-4 (IGFBP-4). Localisation of cleavage site to non-homologous region of native IGFBP-4. J. Biol. Chem. 270, 11377-11382 (1995)
6. Claussen M, Kübler B, Wendland M, Neiffer K, Schmidt B, Zapf J, Braulke T: Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 138, 3797-3803 (1997)
7. Coverley JA, Baxter RC: Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I. Endocrinology 136, 5778-5781 (1995)
8. Ferry RJ Jr, Katz LE, Grimberg A, Cohen P, Weinzimmer SA: Cellular actions of insulin-like growth factor binding proteins. Horm. Metab. Res. 31, 192-202 (1999)
9. Firth SM, Ganeshprasad U, Baxter RC: Structural determinants of ligand and cell surface binding of insulin-like growth factor binding protein-3. J. Biol. Chem. 273, 2631-2638 (1998)
10. Fowlkes JL: Insulin-like growth factor-binding protein proteolysis. An emerging paradigm in insulin-like growth factor physiology. Trends Endocrinol. Metab. 8, 299-305 (1997)
11. Giorgetti S, Ballotti R, Kowalski-Chauvel A, Tartare S, Van Obberghen E: The insulin-like growth factor-I receptor substrate IRS-I associates with and activates phosphatidylinositol 3-kinase. J. Biol. Chem. 268, 7358-7364 (1993)
12. Hartmann H, Meyer-Albert A, Braulke T: Metabolic actions of insulin-like growth factor-II in cultured adult rat hepatocytes are not mediated through the insulin-like growth factor-II receptor. Diabetologia 35, 216-223 (1992)
13. Holzenberger M, Dupont J, Ducos B, Leneuve P et al.: IGF-I receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187 (2003)
14. Hossenlopp P, Segovia B, Lassare C, Roghani M, Bredon M, Binoux M: Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 105 K complex during pregnancy. J. Clin. Endocrinol. Metab. 71, 797-805 (1990)
15. Hwa V, Oh Y, Rosenfeld RG: Insulin-like growth factor binding proteins: a proposed superfamily. Acta Paediatr., Suppl 88, 37-45 (1999)
16. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocrin. Rev. 16, 3-34 (1995)
17. Kenyon C: A conserved regulatory system for aging. Cell 105, 165-168 (2001)
18. Laban C, Bustin SA, Jenkins PJ: The GH-IGF-I axis and breast cancer. Trends Endocrinol. Metab. 14, 28-34 (2003)
19. Lalou C, Lassare C, Binoux M: A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137, 3206-3212 (1996)
20. Leal SM, Huang SS, Huang JS: Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells. J. Biol. Chem. 274, 6711-6717 (1999)
21. Lelbach A, Scharf JG, Ramadori G: Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by interleukin-6. J. Hepatol. 35, 558-567 (2001)
22. Lelbach A., Muzes Gy, Feher J: Molecular mechanisms of cancer cachexia. Orv. Hetil. 145, 2329-2334 (2004)
23. LeRoith D, Bondy C, Yakar S, Liu JL, Butler A: The somatomedin hypothesis. Endocr. Rev. 22, 53-74 (2001)
24. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1r). Cell 75, 59-72 (1993)
25. Louvi A, Accili D, Efstratiadis A: Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev. Biol. 189, 33-48 (1997)
26. Maile LA, Holly JM: Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role and regulation. Growth Horm. IGF Res. 9, 85-89 (1999)
27. Moschos S, Mantzoros Ch: The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63, 317-332 (2002)
28. Nissley P, Kiess W: Reciprocal modulation of binding of lysosomal enzymes and insulin-like growth factor II (IGF-II) to the mannose 6-phosphate/IGF-II receptor. Adv. Exp. Med. Biol. 293, 311-324 (1991)
29. Nykjaer A, Christensen EI, Vorum H, Hager H, Petersen CM, Roigaard H, Min HY, Vilhardt F, Moller LB, Kornfeld S, Gliemann J: Mannose 6-phosphate/insulin- like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J. Cell. Biol. 141, 815-828 (1998)
30. Oh Y, Yamanaka Y, Kim HS, Vorwerk P, Wilson E, Hwa V, Yang DH, Spagnoli A, Wanek D, Rosenfeld RG (1998): IGF-independent actions of IGFBPs. In: Molecular Mechanisms to Regulate the Activities of Insulin-like Growth Factors, Eds V. Takano K, Hizuka N, Takahashi SI, Elsevier Science BV, Amsterdam, pp. 125-133
31. Parker A, Rees C, Clarke J, Busby WH Jr, Clemmons DR: Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol. Biol. Cell 9, 2383-2392 (1998)
32. Radulescu RT: Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem. Sci. 19, 278 (1994)
33. Rajah R, Bhala A, Nunn SE, Peehl DM, Cohen P: 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137, 2676-2682 (1996)
34. Ramadori G, Saile B: Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology 127, 997-1000 (2004)
35. Rosen CJ: Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications. Clin. Chem. 45, 1384-1390 (1999)
36. Scharf JG, Braulke T: The role of the IGF axis in hepatocarcinogenesis. Horm. Metab. Res. 35, 685-693 (2003)
37. Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr. Opin. Cell. Biol. 10, 602-608 (1998)
38. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ: ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J. Biol. Chem. 275, 18574-18580 (2000)
39. Schmidt B, Kiecke-Siemsen C, Waheed A, Braulke T, von Figura K: Localisation of the insulin-like growth factor II binding site to amino acids 1508-1566 in repeat 11 of the mannose 6-phosphate/insulin-like growth factor II receptor. J. Biol. Chem. 270, 14975-14982 (1995)
40. Spencer ME, Chan K: A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBP); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. Prog. Growth factor Res. 6, 209-214 (1995)
41. Tatar M, Bartke A, Antebi A: The endocrin regulation of aging by insulin-like signals. Science 299, 1346-1351 (2003)
42. Thissen JP, Ketelslegers JM, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15, 80-101 (1994)
43. Treadway JL, Frattali AL, Pessin JE: Intramolecular subunit interactions between insulin and insulin-like growth factor 1 alpha beta half-receptors induced by ligand and Mn/MgATP binding. Biochemistry 31, 11801-11805 (1992)
44. Twigg SM, Baxter RC: Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and acid labile subunit. J. Biol. Chem. 273, 6074-6079 (1998)
45. Yu H, Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92, 1472-1489 (2000)
46. Wang ZQ, Fung MR, Barlow DP, Wagner EF: Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372, 464-467 (1994)
47. Withers DJ: Insulin receptor substrate proteins and neuroendocrine function. Biochem. Soc. Trans. 29, 525-529 (2001)
48. Woelfle J, Dennis C, Massart-Schlesinger M, Moyano P, Rotwein P: Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system. Pediatr. Nephrol. (Epub) (2004)
49. Wolk A, Anderson SO, Mantzoros CS, Trichopoulos D, Adami HO: Can measurements of IGF-I and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet 356, 1902-1903 (2000)
50. Zadeh SM, Binoux M: Insulin-like growth factor (IGF) binding protein-3 interacts with the type I IGF receptor, reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action. Endocrinology 138, 5645-5648 (1997)
51. Zapf J: Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132, 645-654 (1995)